BIOHAVEN LTD (BHVN:NYSE)
$15.03 -0.14 (-0.9229%)
Analysed BIOHAVEN LTD (BHVN:NYSE) News Sources
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
29-06-2026
yahoo.com
Why Is BHVN Stock Falling Premarket?
30-06-2026
stocktwits.com
Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator
30-06-2026
yahoo.com
Why Wall Street Is Growing More Cautious on Biohaven (BHVN)
06-07-2026
yahoo.com
BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts
09-07-2026
stocktwits.com
Biohaven (BHVN) Completes Enrollment in RISE3 Trial
09-07-2026
yahoo.com
Biohaven Announces Scientific Leadership Transitions
09-07-2026
yahoo.com
Is Biohaven’s (BHVN) R&D Shake-Up Quietly Redefining Its Late-Stage Pipeline Strategy?
10-07-2026
yahoo.com
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
10-07-2026
biopharmadive.com
Bexorg Expands Leadership Team with Appointments of Bruce Car, Ph.D., as Chief Scientific Officer and Michael Fenn, Ph.D., as Chief Business Officer
13-07-2026
yahoo.com
What is the current price of BIOHAVEN LTD (BHVN:NYSE)?
The current price of BIOHAVEN LTD (BHVN:NYSE) is $15.03.
BIOHAVEN LTD (BHVN:NYSE) absolute price change since previous trading day?
The absolute price change of BIOHAVEN LTD (BHVN:NYSE) since the previous trading day is $-0.14.
BIOHAVEN LTD (BHVN:NYSE) percentage price change since previous trading day?
The percentage price change of BIOHAVEN LTD (BHVN:NYSE) since the previous trading day is -0.9229%.
What is the most recent average sentiment score for BIOHAVEN LTD (BHVN:NYSE)?
The most recent average sentiment score for BIOHAVEN LTD (BHVN:NYSE) is 69 out of 100.
What is the most recent average sentiment for BIOHAVEN LTD (BHVN:NYSE)?
The most recent sentiment for BIOHAVEN LTD (BHVN:NYSE) is .
SEC-8K** Filing Available For BIOHAVEN LTD (BHVN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.